Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 443-860-6 | CAS number: 302776-68-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
90-day repeated dose toxicity (subchronic) study according to OECD TG 408: NOAEL is determined at 15,000 ppm, equivalent to 1248.8 mg/kg bw/day in males and 1452.1 mg/kg bw/day in females.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 1 249 mg/kg bw/day
Additional information
In the key study, a subchronic toxicity study (BASFAG50S0408/99093) according to OECD TG 408, the test substance Hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate was administered to 10 Wistar rats per dose per sex in diet at dose levels of 0 ppm, 600 ppm (in males approx. 51.7 mg/kg bw/day; females: approx. 59.3 mg/kg bw/d), 3000 ppm (in males: approx 250.2 mg/kg bw/d; females: approx 288.0 mg/kg bw/d), 15000 ppm (in males: 1249 mg/kg bw/day; females: approx 1452 mg/kg bw/d) for three months.
No compound related effects in mortality, clinical signs, body weight, food consumption, hematology and clinical chemistry were observed. The distinct clinical findings in one high-dose male which was sacrificed moribund on day 49 were also spontaneous in nature.
No substance related neurobehavioural, ophtalmoscopic effects or effects on sperm parameters were observed.
All gross lesions and microscopic findings recorded were either single observations or they occurred in control animals only, or they were recorded at low or comparable incidence and graded severity in control and high dose males and/or females. Hence, they were all regarded to have developed fortuitously and unrelated to treatment.
The mean relative weights of testes (+9%, high dose group) and heart (female, low dose group +15%) were significantly increased, whereas the mean relative weight of the spleen (mid dose group in females) was significantly decreased (-31%). However, these findings were determined to be not treatment-related as,
- the absolute testes and heart weights were not significantly changed,
- all gross lesions and microscopic findings recorded were either single observations, or occurred in control animals and no dose-response relationship was evident,
- comprehensive examinations of reproductive organs as well as sperm analysis did not give any indication for an impairment of fertility which support a substance related effect. In addition no effects on fertility parameters were noted in the 2-generation study.
The mean relative liver weights in male (+7%) and female rats (+10%) in the high dose group were statistically significantly increased. However the following points support the assumption that the increase in the relative liver weight is rather an incidental observation:
- lack of any morphological changes (gross pathology (lesions) and microscopic findings),
- no significant difference in results of blood chemistry concerning liver related enzymes (aminotransferases and alkaline phosphatases) between the control and the treated groups,
- the absolute liver weights were not significantly altered.
In addition the terminal body weight was slightly although not significantly decreased in both males (-3.6%) and females (-2.5%) of the high dose group. Therefore, the small decrease in body weights effected the statistically significant increase in the liver weights in this group.
Based on the obtained study results and their interpretation, the no observed effect level (NOAEL) under the conditions of the study was therefore 15000 ppm (equal to 1248.8 mg/kg bw/day in males or 1452.1 mg/kg bw/d in females).
Justification for classification or non-classification
The present data on repeated dose toxicity do not fulfill the criteria laid down in 67/548/EEC and 1272/2008/EEC, and therefore, a non-classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.